Home / Stock ratings / MCK
Stock rating · Wholesale-Drugs, Proprietaries & Druggists' Sundries
McKesson Corporation (MCK) Stock Rating & Analysis
As of October 12, 2026, MELANY rates McKesson Corporation 57 out of 100 (Promising). Its highest factor score is catalyst setup at 88, and its lowest is business quality at 8.
MELANY ratingRated 2026-10-12MCK · composite score
About McKesson Corporation
McKesson is one of three leading US pharmaceutical wholesalers, sourcing and distributing branded, generic, and specialty pharmaceuticals to pharmacies (retail chains, independents, and mail order), hospital networks, and healthcare providers. Together with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US, McKesson conducts pharmaceutical wholesale and distribution in Canada.
Rating as of 2026-10-12 · this is a dated snapshot; the live rating is in the app (Pro, free for 30 days). The price above updates in real time.
Why MCK scores 57/100
MCK's 8 factor scores run from 8 to 88, and 4 of them sit above its composite of 57. Here is how MCK breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- FCF yield 6.1%
Margins, returns on capital, and balance-sheet strength.
Direction and relative strength of the recent share-price trend.
- Price +7.7% above 50-day MA
- 50-day MA above 200-day (golden cross zone)
History of beating or missing estimates, and where estimates are heading.
- Beat EPS estimates 4 of last 4 quarters
- Earnings in 23 days (strong beat history)
What Wall Street price targets and revisions are signalling.
Near-term events that could move the stock.
- Earnings in 23 days
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
How MCK compares
As of October 12, 2026, McKesson Corporation ranks 2nd of the 2 companies with a MELANY rating page in its SEC industry group (Wholesale-Drugs, Proprietaries & Druggists' Sundries), where the average score is 60.
Key risks for MCK
- No specific company-level red flags detected, monitor macro regime changes
Sector and theme context
McKesson Corporation sits in the Healthcare sector theme, which MELANY currently rates 65/100 for strength. Theme strength feeds MCK's momentum and catalyst factors above.
MCK trade plan (Pro)
MELANY has a full position plan for McKesson Corporation: a smart entry zone, an alert level, position sizing, and quarterly review triggers. It is part of Market Eyes Pro, and the first 30 days are free.
How MELANY rates MCK
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. McKesson Corporation's 57/100 reflects mature factor weighting for its profile. Position framework managed by score-based check-ins, not a fixed holding period.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about MCK
Is McKesson Corporation (MCK) a buy?
As of 2026-10-12, MELANY rated McKesson Corporation Promising with a composite score of 57/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is McKesson Corporation's MELANY score?
McKesson Corporation (MCK) has a MELANY composite score of 57/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, macro fit.
How is the MCK stock rating calculated?
MELANY scores MCK from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy McKesson Corporation stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates McKesson Corporation (MCK) Promising with a composite of 57/100 as of 2026-10-12. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the MCK stock price forecast?
MELANY does not publish price targets or forecasts for MCK. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 57/100 across eight factors for McKesson Corporation, and re-scores automatically as new price, earnings, and fundamental data arrive.
Is MCK stock overvalued or undervalued?
MELANY's valuation factor currently reads 52/100 for McKesson Corporation, where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives MCK's read.
What price should I buy MCK at?
Rather than chasing the current price, MELANY computes a smart entry zone for MCK: the price area where risk and reward actually favor a new position, plus an alert level and position sizing. The exact levels are part of Market Eyes Pro, which starts with a 30-day free trial.
What are the risks of buying MCK stock?
The top risks MELANY currently flags for McKesson Corporation: No specific company-level red flags detected, monitor macro regime changes. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is McKesson Corporation a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 8/100 for McKesson Corporation, and earnings track record, at 76/100. The 57/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will MCK stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 67/100 for MCK right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this MCK rating?
The rating on this page is a snapshot of MELANY's read as of 2026-10-12. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores MCK continuously as new price, earnings, and fundamental data arrive, and the current rating is in the app (Pro, free for 30 days).
How this rating works
Market Eyes Live
Every rating graded in public, MCK included
MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.